Options
|
Latest data shows the… Latest data shows the largest indicative borrow rate increases among liquid option names include: Direxion Oil & Gas 3x Bull ETF (GUSH) 23.01% +10.40, FaZe Holdings (FAZE) 316.29% +8.71, Krispy Kreme (DNUT) 3.46% +2.30, Vertical Aerospace (EVTL) 647.13% +0.83, Cognyte Software (CGNT) 1.17% +0.75, Altice USA (ATUS) 0.71% +0.34, Hollysys (HOLI) 1.36% +0.33, KnowBe4 (KNBE) 0.79% +0.30, VAALCO Energy (EGY) 0.90% +0.21, and Imperial Petroleum (IMPP) 19.75% +0.19. ShowHide Related Items >><< - 10/12/22
- KnowBe4 to be acquired by Vista Equity Partners for $24.90 per share
- 10/12/22
- KnowBe4 up 12.4% at $24.27 after report of acquisition by Vista Equity
- 09/19/22
- KnowBe4 confirms receipt of $24 per share proposal from Vista
- 09/19/22
- KnowBe4 confirms receipt of $24 per share non-binding bid from Vista Equity
- 10/17/22
- Imperial Petroleum announces adjournment of annual meeting
- 10/10/22
- Imperial Petroleum announces delivery of Japanese built dry bulk carrier
- 09/14/22
- Imperial Petroleum announces adjournment of annual meeting
- 06/13/22
- Imperial Petroleum enters warrant exercise transaction for $21.8M in proceeds
- 09/28/22
- China Health Industries, Hollysys provisionally identified under HFCAA
- 10/04/22
- FaZe Holdings Inc trading resumes
- 10/04/22
- FaZe Holdings Inc trading halted, volatility trading pause
- 09/08/22
- Gamesquare Esports launches Mission Supply merchandise company
- 08/31/22
- FaZe Holdings announces renewal of partnership with McDonald's USA
- 10/19/22
- Vertical Aerospace falls -15.1%
- 10/04/22
- Vertical Aerospace rises 15.4%
- 09/26/22
- Vertical Aerospace falls -6.5%
- 09/26/22
- Vertical Aerospace announces take off of the VX4 eVTOL
- 10/20/22
- Vaalco Energy names Matthew Powers general counsel
- 10/19/22
- Vaalco Energy reports Q3 production 9,150 net BOPD, completes Etame FSO
- 10/07/22
- Vaalco Energy, TransGlobe stockholders approve business combination
- 09/29/22
- Vaalco stockholders approve proposals in connection with TransGlobe combination
- 10/18/22
- Krispy Kreme up 8% after reports of McDonald's testing donut sales partnership
- 09/26/22
- Krispy Kreme offers free coffee on National Coffee Day
- 08/22/22
- Krispy Kreme CEO buys $378K in common stock
- 07/06/22
- Krispy Kreme to give away 8,500 years of free Original Glazed doughnuts
- 09/07/22
- Altice USA names Dennis Mathew as CEO
- 08/04/22
- Altice USA rises 14.6%
- 08/04/22
- Altice USA confirms inquiries for Suddenlink assets in earnings call
- 08/03/22
- Altice USA backs FY22 capex view of $1.7B-$1.8B
- 08/19/22 Citi
- Krispy Kreme price target lowered to $14 from $15 at Citi
- 08/19/22 HSBC
- Krispy Kreme downgraded to Hold from Buy at HSBC
- 08/18/22 Evercore ISI
- Krispy Kreme downgraded to In Line on consumer headwinds at Evercore ISI
- 08/18/22 Evercore ISI
- Krispy Kreme downgraded to In Line from Outperform at Evercore ISI
- 09/12/22 Barclays
- Vertical Aerospace price target lowered to $5 from $7 at Barclays
- 07/27/22 Raymond James
- Vertical Aerospace initiated with a Market Perform at Raymond James
- 04/11/22 Deutsche Bank
- Vertical Aerospace initiated with a Hold at Deutsche Bank
- 01/18/22 Barclays
- Vertical Aerospace initiated with an Underweight at Barclays
- 09/28/22 Stifel
- Cognyte downgraded to Hold from Buy at Stifel
- 06/29/22 Evercore ISI
- Cognyte downgraded to In Line at Evercore ISI after 'disappointing' results
- 06/29/22 Evercore ISI
- Cognyte downgraded to In Line from Outperform at Evercore ISI
- 06/28/22 William Blair
- Cognyte downgraded on lack of revenue visibility at William Blair
- 10/18/22 Deutsche Bank
- Altice USA price target lowered to $9 from $12 at Deutsche Bank
- 10/13/22 Morgan Stanley
- Altice USA price target lowered to $7 from $11 at Morgan Stanley
- 10/13/22 Citi
- Altice USA upgraded to Buy from Neutral at Citi
- 09/30/22 Credit Suisse
- Altice USA price target lowered to $7 from $14 at Credit Suisse
- 10/18/22 Cowen
- KnowBe4 downgraded to Market Perform from Outperform at Cowen
- 10/14/22 Berenberg
- KnowBe4 downgraded to Hold from Buy at Berenberg
- 10/13/22 DA Davidson
- KnowBe4 downgraded to Neutral from Buy at DA Davidson
- 10/13/22 Canaccord
- KnowBe4 downgraded to Hold from Buy at Canaccord
- 08/04/22
- KnowBe4 sees Q3 revenue $85M-$86M, consensus $85.45M
- 08/04/22
- KnowBe4 raises FY22 revenue view to $333M-$334M from $331M-$333M
- 08/04/22
- KnowBe4 reports Q2 adjusted EPS 7c, consensus 2c
- 08/03/22
- Notable companies reporting before tomorrow's open
- 07/27/22
- Imperial Petroleum reports Q2 EPS 0c vs (17c) last year
- 06/14/22
- Imperial Petroleum reports Q1 EPS (9c) vs (1c) last year
- 08/17/22
- Krispy Kreme sees FY22 revenue $1.49B-$1.52B , consensus $1.56B
- 08/17/22
- Krispy Kreme reports Q2 EPS 8c consensus 9c
- 05/11/22
- Krispy Kreme backs long-term outlook of organic revenue growth 9%-11%
- 05/11/22
- Krispy Kreme sees FY22 adjusted EPS 38c-41c, consensus 41c
- 09/28/22
- Cognyte reports Q2 EPS (4c), consensus (17c)
- 06/28/22
- Cognyte reports Q1 EPS (79c), consensus 10c
- 08/03/22
- Altice USA reports Q2 EPS 23c, consensus 32c
- 08/03/22
- Notable companies reporting after market close
- 04/28/22
- Altice USA reports Q1 EPS 43c, consensus 32c
- 04/28/22
- Notable companies reporting after market close
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 10/12/22
- Wipro sees Q3 IT Services revenue $2.811B-$2.853B
- 09/01/22
- Wipro achieves AWS Energy Competency status
- 06/16/22
- ShiftLeft in strategic Investment from and go-to-market deal with Wipro
- 06/15/22
- Wipro, Immuta expand partnership for Snowflake solutions
- 09/29/22
- Merck says appeals court rules in company's favor on sitagliptin patent
- 09/22/22
- Merck granted favorable rule in sitagliptin patent lawsuit against Viatris
- 09/21/22
- Mapi Pharma says GA Depot Phase III trial meets primary endpoint
- 10/12/22
- T2 Biosystems announces 50-for-1 reverse stock split
- 09/29/22
- T2 Biosystems announces BARDA exercise of contract option 3 valued at $3.7M
- 09/22/22
- T2 Biosystems announces commercial expansion though distributor in Baltic Region
- 08/16/22
- T2 Biosystems seeks shareholder approval for reverse stock split
SWK Stanley Black & Decker - 08/04/22
- Stanley Black & Decker director buys $1.48M in common stock
- 07/28/22
- Stanley Black & Decker announces cost saving initiatives
- 07/20/22
- Stanley Black & Decker raises quarterly dividend to 80 from 79c per share
- 07/05/22
- Stanley Black & Decker completes sale of Access Technologies to Allegion
- 06/22/22
- President Biden calls on Congress to suspend federal gas tax
- 06/14/22
- Ackman says 75 point hike tomorrow can help restore confidence in Fed
- 06/07/22
- Global growth to fall to 2.9% in 2022 from 5.7% in 2021, World Bank says
- 05/19/22
- Could crypto crash be good for U.S. economy? Probably.
- 10/12/22
- Sientra signs senior secured loan facilities with Deerfield Management
- 10/03/22
- Sientra launches educational programs for Breast Cancer Awareness Month
- 09/20/22
- Sientra receives regulatory approval to market breast implants in Saudi Arabia
- 09/08/22
- FDA issues safety communication on reports of cancers around breast implants
- 09/28/22
- Superior Drilling awarded $750,000 grant to expand manufacturing operations
- 05/19/22
- Superior Drilling regains compliance with NYSE American listing standards
- 05/10/22
- Star Equity issues open letter to Superior Drilling board
- 10/12/22
- Rocket Lab announces arrival of Electron rocket at Launch Complex 2 in Virginia
- 10/11/22
- Cathie Wood's ARK Investment bought 135K shares of Rocket Lab today
- 10/10/22
- Cathie Wood's ARK Investment bought 64.6K shares of Rocket Lab today
- 10/06/22
- Cathie Wood's ARK Investment bought 94K shares of Rocket Lab today
- 10/12/22
- Philips falls -11.4%
- 10/12/22
- Philips falls -12.2%
- 09/30/22
- Philips appoints Jakobs as next president, CEO
- 09/15/22
- Philips highlights FetView cloud-based image sharing, reporting software
- 10/12/22
- Pfizer, BioNTech receive FDA EUA for Omicron BA.4/BA.5-adapted bivalent vaccine
- 10/07/22
- Pfizer-BioNTech omicron booster approved by Health Canada for ages 12 and up
- 10/04/22
- Biohaven launches as a new publicly traded company
- 10/10/22
- VPX Sports, maker of Bang Energy drinks, seeks Chapter 11 bankruptcy protection
- 10/06/22
- Tesla's Musk says to make first Semi Truck deliveries to Pepsi on December 1
- 09/29/22
- PepsiCo offering buyouts to employees 55+, Fox Business' Gasparino says
- 09/20/22
- SaverOne 2014: SaverOne Systems to be installed across Strauss Frito-Lay fleet
- 10/12/22
- Owens & Minor falls -30.7%
- 10/12/22
- Owens & Minor falls -22.4%
- 10/12/22
- Owens & Minor falls -21.1%
- 10/12/22
- Owens & Minor appoints Andrew Long, EVP, CEO, Products & Healthcare Services
NCLH Norwegian Cruise Line - 10/06/22
- Norwegian Cruise Line CFO says liquidity position better than plan
- 10/06/22
- Norwegian Cruise Line targeting 'record' net yield, adjusted EBITDA for FY
- 10/06/22
- Norwegian Cruise Line sees return to historical load factors in 2023
- 10/06/22
- Norwegian Cruise Line: Booking trends for FY23 'positive'
- $130.73 /
+10.005 (+8.29%) - 10/12/22
- Moderna receives FDA EUA for Omicron-targeting bivalent COVID-19 booster vaccine
- 10/12/22
- FDA authorizes new Moderna, Pfizer boosters for younger age groups
- 10/12/22
- Moderna exercises option to license Autolus Therapeutics' targeting technology
- 10/12/22
- Merck exercises option for joint development, commercialization of PCV
- 10/12/22
- Royalty Pharma enters schizophrenia R&D funding collaboration with Merck
- 10/11/22
- Ginkgo Bioworks announces collaboration with Merck
- 10/10/22
- Merck reports 'positive' results from Phase 3 STELLAR trial
- 10/12/22
- MGP Ingredients falls 5% to $96.05 following Spruce Point short report
- 10/03/22
- MGP Ingredients appoints Matt Krusemark as VP, sales, Distilling Solutions
- 09/14/22
- MGP Ingredients names Landherr Chief Legal Officer
- 10/11/22
- Lyft says 'no immediate or direct impact' on business from DOL proposed rule
- 10/11/22
- Uber, others under pressure on Department of Labor gig worker proposal
- 10/11/22
- Uber, Lyft sink following reports on Department of Labor gig worker proposal
- 10/10/22
- SmileDirectClub appoints Ali as VP of Product
- 10/12/22
- KnowBe4 to be acquired by Vista Equity Partners for $24.90 per share
- 10/12/22
- KnowBe4 up 12.4% at $24.27 after report of acquisition by Vista Equity
- 09/19/22
- KnowBe4 confirms receipt of $24 per share proposal from Vista
- 09/19/22
- KnowBe4 confirms receipt of $24 per share non-binding bid from Vista Equity
- 10/11/22
- Intel introduces internal foundry model for external customers, product lines
- 10/11/22
- Google launches C3 machine series for data centers with Intel
- 09/28/22
- Valens Semiconductor, Intel collaborate on MIPI A-PHY technology
- 09/27/22
- Intel unveils 13th Gen Intel Core Processor family
- 08/29/22
- Farfetch falls -11.9%
- 08/26/22
- Farfetch rises 27.3%
- 08/26/22
- Farfetch rises 24.4%
- 08/26/22
- Farfetch rises 24.0%
- $51.23 /
-7.685 (-13.04%) - 10/12/22
- Enviva falls -17.5%
- 10/06/22
- Enviva Partners appoints Mark Coscio as CDO
- 10/03/22
- Enviva Partners sees FY22 capital expenditures $255M-$275M
- 10/03/22
- Enviva Partners provides update on Q3, Q4 adjusted EBITDA outlook
- 10/06/22
- Netflix film 'Glass Onion' to have theatrical release before streaming debut
- 09/22/22
- Cinemark, D-BOX expand relationship with agreement for recliner seats
- 08/17/22
- Cineworld evaluates strategic options amid slow attendance, limited film slate
- 07/01/22
- Cinemark says June box office performance 'best in more than two years'
- $22.31 /
-3.495 (-13.54%) - 10/12/22
- Cameco falls -15.5%
- 10/12/22
- Cameco falls -12.6%
- 10/12/22
- Cameco falls -13.2%
- 10/11/22
- Cameco sees Q3 uranium deliveries 5M-5.5M pounds
- 10/11/22
- Cango declares special cash dividend of 50c per share
- 06/16/22
- Cango rises 41.0%
- 05/19/22
- Cango announces Liu to resign as a director of the company
- 04/26/22
- Cango falls -7.5%
- 10/06/22
- BioNTech to establish mRNA research/manufacturing facility in Victoria
BEP Brookfield Renewable Partners - 10/11/22
- Cameco, Brookfield Renewable partner to acquire Westinghouse Electric
- 10/03/22
- LanzaTech, Brookfield form strategic partnership with initial $500M commitment
- 09/29/22
- Brookfield to invest up to $2B in Scout Clean Energy, Standard Solar
- 05/13/22
- Juniper appoints Steve Fernandez to board of directors
- 10/11/22
- Apple introduces Ask Apple for developers
- 10/07/22
- Meta identifies over 400 malicious Android, iOS apps aiming to steal login info
- 10/04/22
- Phones, tablets, cameras sold in EU forced to use USB-C for charging by 2024-end
- 09/28/22
- Block's Square launches Tap to Pay on iPhone
- 05/12/22
- Miller calls out Taylor Morrison, GM as names that may work in this environment
- 04/21/22
- Powell says 50 basis point hike on table for May meeting
- 10/13/22 RBC Capital
- PepsiCo price target raised to $170 from $165 at RBC Capital
- 10/13/22 Wedbush
- PepsiCo price target raised to $190 from $185 at Wedbush
- 10/10/22 Wedbush
- PepsiCo initiated with an Outperform at Wedbush
- 10/10/22 Wedbush
- PepsiCo initiated with an Outperform at Wedbush
- 10/13/22 Morgan Stanley
- Morgan Stanley says Merck opt-in suggests confidence in Moderna PCV data
- 10/12/22 Piper Sandler
- Merck move positive signal for Moderna, says Piper Sandler
- 10/12/22 Barclays
- Merck price target raised to $105 from $101 at Barclays
- 10/11/22 Truist
- Merck price target raised to $103 from $95 at Truist
- $130.73 /
+10.005 (+8.29%) - 09/14/22 Argus
- Moderna price target lowered to $150 from $180 at Argus
- 09/07/22 Deutsche Bank
- Moderna upgraded to Buy with $165 target at Deutsche Bank
- 10/13/22 DA Davidson
- KnowBe4 downgraded to Neutral from Buy at DA Davidson
- 10/13/22 Canaccord
- KnowBe4 downgraded to Hold from Buy at Canaccord
- 10/12/22 Wolfe Research
- KnowBe4 downgraded to Peer Perform from Outperform at Wolfe Research
- 10/12/22 Truist
- KnowBe4 downgraded to Hold from Buy at Truist
- 10/13/22 Oddo BHF
- Philips downgraded to Neutral from Outperform at Oddo BHF
- 10/07/22 UBS
- Philips price target lowered to EUR 16.10 from EUR 16.40 at UBS
- 10/06/22 Deutsche Bank
- Philips price target lowered to EUR 18 from EUR 22 at Deutsche Bank
- 09/12/22 Societe Generale
- Societe Generale upgrades 'undemandingly valued' Philips to Buy
- 10/07/22 JPMorgan
- JPMorgan changes November rate hike assumption after jobs data
- 09/26/22 JPMorgan
- JPMorgan says stocks oversold amid 'encouraging' inflation signs
- 09/23/22 Goldman Sachs
- Goldman Sachs lowers S&P 500 year-end target to 3,600
- 09/16/22 JPMorgan
- JPMorgan sees 75 point hike next week, 50 point hike in November
SPY SPDR S&P 500 ETF Trust NCLH Norwegian Cruise Line - 10/12/22 UBS
- UBS upgrades Norwegian Cruise to Buy on improved bookings
- 10/12/22 UBS
- Norwegian Cruise Line upgraded to Buy from Neutral at UBS
- 10/04/22 Morgan Stanley
- Carnival price target lowered to $6 from $7 at Morgan Stanley
- 09/20/22 Truist
- Norwegian Cruise Line upgraded to Buy at Truist amid bookings increase
- 10/12/22 B. Riley
- Cinemark price target lowered to $17 from $23 at B. Riley
- 10/12/22 Credit Suisse
- Cinemark double downgraded to Underperform from Outperform at Credit Suisse
- 10/10/22 JPMorgan
- Cinemark price target lowered to $15 from $19 at JPMorgan
- 10/05/22 Benchmark
- Cinemark price target lowered to $22 from $27 at Benchmark
- 10/12/22 Mizuho
- Mizuho sees 'limited' risk to Uber, Lyft from DOL proposal
- 10/12/22 Gordon Haskett
- Gordon Haskett upgrades Lyft to Buy on 'overly negative' sentiment
- 10/12/22 Gordon Haskett
- Lyft upgraded to Buy from Hold at Gordon Haskett
- 10/12/22 Deutsche Bank
- DOL proposal lowers bar for workers to be employees, says Deutsche Bank
- 10/12/22 Jefferies
- AIG upgraded to Buy at Jefferies on 'underappreciated' P&C momentum
- 10/12/22 Jefferies
- AIG upgraded to Buy from Hold at Jefferies
- 10/10/22 Jefferies
- Corebridge initiated with a Buy at Jefferies
- 10/10/22 Oppenheimer
- Corebridge initiated with an Outperform at Oppenheimer
SWK Stanley Black & Decker - 10/13/22 Deutsche Bank
- Stanley Black & Decker price target lowered to $90 from $111 at Deutsche Bank
- 10/12/22 Morgan Stanley
- Stanley Black & Decker downgraded at Morgan Stanley on market softening
- 10/12/22 Morgan Stanley
- Stanley Black & Decker downgraded to Equal Weight at Morgan Stanley
- 10/03/22 Barclays
- Stanley Black & Decker price target lowered to $118 from $120 at Barclays
- 10/13/22 Lake Street
- MGP Ingredients short report 'nothing but clickbait,' says Lake Street
- 10/12/22 Truist
- Truist sees pullback in MGP shares after short report as a buying opportunity
- 10/10/22 Wedbush
- Wedbush starts MGP at Outperform on favorable industry dynamics
- 10/10/22 Wedbush
- MGP Ingredients initiated with an Outperform at Wedbush
- $51.23 /
-7.685 (-13.04%) - 10/12/22 Raymond James
- Enviva short report claims 'old news' or 'erroneous,' says Raymond James
- 09/15/22 Raymond James
- Enviva upgraded to Outperform at Raymond James after EU biopower vote
- 09/15/22 Raymond James
- Enviva Partners upgraded to Outperform from Market Perform at Raymond James
- 08/19/22 RBC Capital
- Enviva Partners downgraded to Sector Perform from Outperform at RBC Capital
- 06/13/22 UBS
- Viatris initiated with a Sell at UBS
- 06/13/22 UBS
- Viatris initiated with a Sell at UBS
- 05/10/22 Piper Sandler
- Viatris downgraded to Underweight from Neutral at Piper Sandler
- 03/16/22 Piper Sandler
- Viatris price target lowered to $10 from $17 at Piper Sandler
- 10/12/22 Barclays
- Intel price target lowered to $30 from $35 at Barclays
- 10/11/22 Needham
- Intel price target lowered to $32 from $40 at Needham
- 10/11/22 Wells Fargo
- Intel price target lowered to $32 from $45 at Wells Fargo
- 10/10/22 Northland
- Intel price target lowered to $52 from $55 at Northland
- 10/13/22 Credit Suisse
- Apple price target lowered to $190 from $201 at Credit Suisse
- 10/13/22 Piper Sandler
- Apple remains dominant device brand among teens, says Piper Sandler
- 10/12/22 Citi
- Citi 'not fearful or concerned' about Apple earnings report
- 10/12/22 Wells Fargo
- Wells names Farfetch 'Top Pick' after Platform Solutions deep dive
- 10/11/22 Morgan Stanley
- Farfetch recent deals 'underappreciated and mis-priced,' says Morgan Stanley
- 09/26/22 Citi
- Farfetch initiated with a Sell at Citi
- 08/30/22 Cowen
- Farfetch price target raised to $11 from $9 at Cowen
- $22.31 /
-3.495 (-13.54%) - 08/17/22 GLJ Research
- Cameco price target raised to C$48.40 from C$37.86 at GLJ Research
- 08/02/22 Scotiabank
- Cameco price target raised to C$44 from C$43 at Scotiabank
- 07/07/22 Scotiabank
- Cameco price target lowered to C$43 from C$47 at Scotiabank
- 05/06/22 Canaccord
- Cameco price target lowered to C$43 from C$44 at Canaccord
BEP Brookfield Renewable Partners - 09/30/22 TD Securities
- TD upgrades Brookfield Renewable Partners to Action List Buy on pullback
- 09/30/22 TD Securities
- Brookfield Renewable upgraded to Action List Buy from Buy at TD Securities
- 09/30/22 Mizuho
- Brookfield Renewable Partners price target lowered to $33 from $38 at Mizuho
- 08/08/22 Desjardins
- Brookfield Renewable price target raised to C$50 from C$49 at Desjardins
- 10/11/22 Credit Suisse
- Rocket Lab initiated with Underperform on 'several risks' at Credit Suisse
- 10/11/22 Credit Suisse
- Rocket Lab initiated with an Underperform at Credit Suisse
- 10/07/22 Deutsche Bank
- Rocket Lab can corner high-value satellite components market, says Deutsche
- 09/13/22 Deutsche Bank
- Rocket Lab named short-term idea at Deutsche Bank
- 10/13/22 Citi
- Owens & Minor downgraded to Neutral from Buy at Citi
- 10/12/22 BofA
- BofA double downgrades Owens & Minor with 'too much unknown'
- 10/12/22 BofA
- Owens & Minor downgraded to Underperform from Buy at BofA
- 10/12/22 Baird
- Baird downgrades Owens & Minor to Neutral after guidance cut
- 09/16/22 Lake Street
- Sientra price target lowered to $2 from $8 at Lake Street
- 05/13/22 Canaccord
- Sientra price target lowered to $5 from $8 at Canaccord
- 04/14/22 Lake Street
- Sientra initiated with a Buy at Lake Street
- 03/29/22 Canaccord
- Sientra price target lowered to $8 from $10 at Canaccord
- 07/07/22 Alliance Global Partners
- T2 Biosystems downgraded to Neutral from Buy at Alliance Global Partners
- 07/07/22 BTIG
- T2 Biosystems downgraded on 'broad-based' shortfall at BTIG
- 07/07/22 BTIG
- T2 Biosystems downgraded to Neutral from Buy at BTIG
- 02/18/22 Alliance Global Partners
- T2 Biosystems upgraded to Buy from Neutral at Alliance Global Partners
- 06/09/22 EF Hutton
- Superior Drilling initiated with a Buy at EF Hutton
- 10/13/22 Credit Suisse
- Wipro downgraded to Underperform from Neutral at Credit Suisse
- 09/13/22 Goldman Sachs
- Goldman double upgrades Wipro to Buy on attractive valuation
- 09/13/22 Goldman Sachs
- Wipro upgraded to Buy from Sell at Goldman Sachs
- 07/20/22 Citi
- Wipro downgraded to Sell at Citi after 'disappointing' Q1
- 10/12/22 Barclays
- Pfizer price target lowered to $44 from $50 at Barclays
- 10/11/22 SVB Securities
- Pfizer price target lowered to $48 from $53 at SVB Securities
- 09/20/22 Citi
- Citi opens 'upside catalyst watch' on Alnylam Pharmaceuticals
- 09/13/22 Truist
- Concert Pharmaceuticals price target raised to $25 from $22 at Truist
- 09/02/22 Cantor Fitzgerald
- Cantor says ACIP recommendations support 'continued tail' for COVID-19 vaccines
- 08/17/22 Cowen
- BioNTech initiated with a Market Perform at Cowen
- 08/10/22 H.C. Wainwright
- BioNTech price target lowered to $272 from $283 at H.C. Wainwright
- 10/12/22
- Wipro reports Q2 EPS 6c, one estimate 7c
- 07/20/22
- Wipro sees Q2 IT Services revenue $2.817B-$2.872B
- 07/20/22
- Wipro reports Q1 EPS 6c, one estimate 8c
- 04/29/22
- Wipro reports Q4 EPS 7c, two estimates 8c
- 08/08/22
- Viatris reports Q2 EPS 26c, consensus 83c
- 05/09/22
- Viatris sees 2022 revenue $17B-$17.5B, consensus $17.24B
- 05/09/22
- Viatris reports Q1 EPS 33c, consensus 83c
- 10/12/22
- T2 Biosystems sees 2022 revenue $22M-$23M, consensus $28.5M
- 10/12/22
- T2 Biosystems sees Q3 revenue $3.7M, consensus $7.2M
- 08/15/22
- T2 Biosystems reports Q2 EPS (10c) vs. (8c) last year
- 07/06/22
- T2 Biosystems sees 2022 revenue $28M-$31M, consensus $29.33M
SWK Stanley Black & Decker - 07/28/22
- Stanley Black & Decker cuts FY22 EPS view to $5.00-$6.00 from $9.50-$10.50
- 07/28/22
- Stanley Black & Decker reports Q2 adjusted EPS $1.77, consensus $2.12
- 06/01/22
- Stanley Black & Decker backs FY22 EPS view $9.50-$10.50, consensus $9.86
- 04/28/22
- Stanley Black & Decker cuts FY22 EPS view to $9.50-$10.50 from $12.00-$12.50
- 06/14/22
- Ackman says 100 point hike tomorrow 'would be better' than 75
- 10/12/22
- Sientra reiterates 2022 revenue view $90M-$95M, consensus $90.85M
- 10/12/22
- Sientra sees Q3 revenue $21.5M-$22.5M, consensus $21.65M
- 05/12/22
- Sientra reports Q1 EPS (29c), consensus (24c)
- 10/12/22
- Superior Drilling sees 2022 revenue $22M-$25M
- 10/12/22
- Superior Drilling sees Q3 revenue $4.8M-$5.2M
- 05/13/22
- Superior Drilling reports Q1 EPS 1c vs. (4c) last year
- 08/11/22
- Rocket Lab sees Q3 revenue $60M-$63M, consensus $54.4M
- 08/11/22
- Rocket Lab reports Q2 EPS (8c) vs. (21c) last year
- 08/11/22
- Notable companies reporting after market close
- 05/16/22
- Rocket Lab sees Q2 revenue $51M-$54M, consensus $59.2M
- 10/12/22
- Philips sees Q3 group revenue EUR 4.3B
- 07/25/22
- Philips reports Q2 adjusted EPS EUR 0.14 vs. EUR 0.40 last year
- 04/25/22
- Philips reports Q1 adjusted EPS EUR 0.28 vs. EUR 0.15 last year
- 07/28/22
- Pfizer raises FY22 adjusted EPS view to $6.30-$6.45 from $6.25-$6.45
- 07/28/22
- Pfizer reports Q2 adjusted EPS $2.04, consensus $1.80
- 07/27/22
- Notable companies reporting before tomorrow's open
- 10/12/22
- PepsiCo raises FY22 core EPS view to approx. $6.73 from $6.63
- 10/12/22
- PepsiCo raises FY22 core constant currency EPS growth view to 10% from 8%
- 10/12/22
- PepsiCo reports Q3 core EPS $1.97, consensus $1.84
- 10/11/22
- Notable companies reporting before tomorrow's open
- 10/12/22
- Owens & Minor lowers 2022 adjusted EPS view $2.50-$2.60 from $2.85-$3.15
- 10/12/22
- Owens & Minor sees Q3 adjusted EPS 39c-41c, consensus 51c
- 08/03/22
- Owens & Minor cuts FY22 adjusted EPS view to $2.85-$3.15 from $3.05-$3.55
- 08/03/22
- Owens & Minor reports Q2 adjusted EPS 76c, consensus 76c
NCLH Norwegian Cruise Line - 08/09/22
- Norwegian Cruise Line sees Q3 revenue $1.5B-$1.6B, consensus $1.88B
- 08/09/22
- Norwegian Cruise Line reports Q2 adjusted EPS ($1.14), consensus (86c)
- 08/08/22
- Notable companies reporting before tomorrow's open
- $130.73 /
+10.005 (+8.29%) - 08/03/22
- Moderna reports Q2 GAAP EPS $5.24, consensus $4.55
- 05/04/22
- Moderna reports Q1 GAAP EPS $8.58, consensus $5.21
- 05/03/22
- Notable companies reporting before tomorrow's open
- 10/11/22
- Compass Therapeutics announces agreement with Merck
- 09/27/22
- Merck's KEYTRUDA receives four new approvals from Japan's MHLW
- 07/28/22
- Merck narrows FY22 adjusted EPS view to $7.25-$7.35 from $7.24-$7.36
- 07/28/22
- Merck reports Q2 adjusted EPS $1.87, consensus $1.69
- 08/04/22
- MGP Ingredients raises FY22 adjusted EPS $4.41-$4.65 from $4.15-$4.35
- 08/04/22
- MGP Ingredients reports Q2 EPS $1.15, consensus 94c
- 05/05/22
- MGP Ingredients raises FY22 adjusted EPS view $4.15-$4.35 from $3.85-$4.10
- 05/05/22
- MGP Ingredients reports Q1 adjusted EPS $1.69, consensus 95c
- 08/04/22
- Lyft sees Q3 revenue $1.040B-$1.060B, consensus $1.12B
- 08/04/22
- Lyft reports Q2 active riders 19.86M, up 15.9%
- 08/04/22
- Lyft reports Q2 revenue $990.7M, consensus $990.46M
- 08/04/22
- Notable companies reporting after market close
- 08/04/22
- KnowBe4 sees Q3 revenue $85M-$86M, consensus $85.45M
- 08/04/22
- KnowBe4 raises FY22 revenue view to $333M-$334M from $331M-$333M
- 08/04/22
- KnowBe4 reports Q2 adjusted EPS 7c, consensus 2c
- 08/03/22
- Notable companies reporting before tomorrow's open
- 07/28/22
- Intel cuts FY22 adjusted EPS view to $2.30, consensus $3.42
- 07/28/22
- Intel sees Q3 adjusted EPS 35c, consensus 87c
- 07/28/22
- Intel cuts FY revenue view to $65B-$68B, consensus $74.34B
- 07/28/22
- Intel reports Q2 adjusted EPS 29c, consensus 69c
- 08/25/22
- Farfetch reports Q2 EPS (21c), consensus (32c)
- 05/26/22
- Farfetch reports Q1 EPS (24c), consensus (28c)
- $51.23 /
-7.685 (-13.04%) - 08/03/22
- Enviva backs FY22 adjusted EBITDA $230M-$270M
- 08/03/22
- Enviva reports Q2 revenue $296.3M, consensus $286.26M
- 06/21/22
- Enviva backs FY22 adjusted EBITDA view $230M-$270M
- 05/04/22
- Enviva Partners reports Q1 revenue $233M, consensus $261.94M
- 08/05/22
- Cinemark reports Q2 EPS (61c), consensus 23c
- 08/04/22
- Notable companies reporting before tomorrow's open
- 05/06/22
- Cinemark reports Q1 EPS (62c), consensus (61c)
- $22.31 /
-3.495 (-13.54%) - 07/27/22
- Cameco reports Q2 adjusted EPS 18c, consensus (1c)
- 05/05/22
- Cameco reports Q1 adjusted EPS 4c, consensus (2c)
- 08/29/22
- Cango reports Q2 (21c) EPS , two estimates (5c)
- 08/08/22
- BioNTech backs FY22 COVID-19 vaccine revenue view EUR 13B-EUR 17B
- 08/08/22
- BioNTech reports Q2 EPS EUR 6.45 vs. EUR 10.77 last year
- 05/09/22
- BioNTech reports Q1 EPS EUR 14.24 vs. EUR 4.39 last year
BEP Brookfield Renewable Partners - 08/05/22
- Brookfield Renewable Partners reports Q2 normalized FFO 48c vs. 53c a year ago
- 05/06/22
- Brookfield Renewable Partners reports Q1 normalized FFO 45c vs. 38c a year ago
- 08/08/22
- AIG reports Q2 adjusted EPS $1.19, consensus $1.10
- 08/08/22
- Notable companies reporting after market close
- 05/03/22
- AIG reports Q1 adjusted EPS $1.30, consensus $1.18
- 05/03/22
- Notable companies reporting after market close
- 07/28/22
- Apple reports Q3 EPS $1.20, consensus $1.16
- 07/28/22
- Notable companies reporting after market close
- 04/28/22
- Apple says y/y Q3 revenue growth to be impacted by COVID
- 04/28/22
- Apple reports Q2 EPS $1.52, consensus $1.43
|